-transparent.png){kind=logo}
Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives. 2024
State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, and School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.
Cancer, as a public health issue, is the leading cause of death worldwide. Tetrahydroisoquinoline derivatives have effective biological activities and can be used as potential therapeutic agents for antitumor drugs. In this work, we designed and synthesized a series of novel tetrahydroisoquinoline compounds and evaluated their antitumor activity in vitro on several representative human cancer cell lines. The results showed that the vast majority of compounds showed good inhibitory activities against the cancer cell lines of HCT116, MDA-MB-231, HepG2, and A375.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
March 2017,
Chemical biology & drug design,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
February 2023,
Chemical biology & drug design,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
October 2015,
Bioorganic & medicinal chemistry letters,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
December 2023,
Archiv der Pharmazie,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
July 2019,
Bioorganic & medicinal chemistry letters,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
March 2014,
Chemical biology & drug design,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
July 2016,
Bioorganic & medicinal chemistry,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
May 2018,
Bioorganic & medicinal chemistry,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
June 2019,
Anti-cancer drugs,
Can Pang, and
Jianbo Zhao, and
Shuai Zhang, and
Jiayu Chen, and
Xiu Zeng, and
Hao Li
September 2008,
Bioorganic & medicinal chemistry,
